Publisher Future Science Ltd has announced the launch of a new title - Clinical Investigation. The journal is the latest addition to the Future Science's collection of titles addressing those areas that most impact our daily lives (available at www.future-science.com).
Clinical Investigation is dedicated to systematic coverage of the methodology, progress and outcomes of clinical trials. As a peer-reviewed, monthly publication the journal provides a forum for the rapid publication of original research and critically reviews the latest developments in medical research, from Phase I trials through to post-marketing studies and pharmacoeconomic research.
The journal addresses contemporary issues in clinical drug development and methodology, and also provides a platform for the rapid publication of new drug data from human studies. Coverage spans all therapeutic areas and relates to conventional small-molecule drugs as well as biotech-derived therapeutic entities, including vaccines, monoclonal antibodies, antisense, cell and gene therapies and recombinant proteins. The journal publishes review articles, original papers, perspectives, commentaries, meeting reports, news, views and more.
Prof. E. Michael Lewiecki, Senior Editor, is responsible for the editorial direction of Clinical Investigation. He will be supported by a team of Associate Editors and experts making up the international Editorial Advisory board.
Search for more Clinical Research related STM Journals
To access our daily STM news feed through your iPhone, iPad, or other smartphones, please visit www.myscoope.com for a mobile friendly reading experience.
